FDA Clearance Tracker · K251191
Collagen Dura Regeneration Membrane - Repair
Last checked: Nov 20, 2026Latest source record: Nov 18, 2025 (this decision)Source: openFDAMethods & limitations
Decided
Nov 18, 2025
Substantially Equivalent
Time to decision
215 days
Received Apr 17, 2025. Calendar days, including time FDA spent waiting on the applicant.
Pathway
510(k)
Traditional
Device class
Class II
The decision
- FDA number
- K251191
- Device name
- Collagen Dura Regeneration Membrane - Repair
- Applicant
- Collagen Matrix, Inc.
- Applicant location
- Oakland, NJ
- Received
- Apr 17, 2025
- Decided
- Nov 18, 2025
- Decision
- Substantially Equivalent
- Submission type
- Traditional
Device type
- Device type
- Dura Substitute (GXQ)
- Device class
- Class II
- Regulation
- 21 CFR 882.5910
- Specialty
- Neurology & Neurosurgery
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- It is not the first decision under product code GXQ. The earliest in FDA's data is K950956, decided Jun 2, 1995.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
- FDA database record for K251191
- 510(k) summary (PDF) · FDA posts these some weeks after the decision, so a recent one may not open yet.
The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.
Other decisions for Collagen Matrix, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K243071 · Decided Dec 19, 2024 · 83 days after receipt
Device type: Wound Dressing With Animal-Derived Material(S) (KGN) · General & Plastic Surgery
K242302 · Decided Oct 2, 2024 · 58 days after receipt
Device type: Scaffold, Partial Medial Meniscal Defects Extending Into The Red/White Zone, Resorbable Bovine Collagen (OLC) · General & Plastic Surgery
K233203 · Decided May 1, 2024 · 216 days after receipt
Device type: Barrier, Animal Source, Intraoral (NPL) · Dentistry & Oral Surgery
5 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.